1. Home
  2. BDTX vs RMM Comparison

BDTX vs RMM Comparison

Compare BDTX & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • RMM
  • Stock Information
  • Founded
  • BDTX 2014
  • RMM 2019
  • Country
  • BDTX United States
  • RMM United States
  • Employees
  • BDTX N/A
  • RMM N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • RMM Trusts Except Educational Religious and Charitable
  • Sector
  • BDTX Health Care
  • RMM Finance
  • Exchange
  • BDTX Nasdaq
  • RMM Nasdaq
  • Market Cap
  • BDTX 132.5M
  • RMM 271.2M
  • IPO Year
  • BDTX 2020
  • RMM N/A
  • Fundamental
  • Price
  • BDTX $2.61
  • RMM $13.58
  • Analyst Decision
  • BDTX Strong Buy
  • RMM
  • Analyst Count
  • BDTX 6
  • RMM 0
  • Target Price
  • BDTX $14.83
  • RMM N/A
  • AVG Volume (30 Days)
  • BDTX 1.2M
  • RMM 66.5K
  • Earning Date
  • BDTX 08-05-2025
  • RMM 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • RMM 7.33%
  • EPS Growth
  • BDTX N/A
  • RMM N/A
  • EPS
  • BDTX 0.09
  • RMM 0.96
  • Revenue
  • BDTX $70,000,000.00
  • RMM N/A
  • Revenue This Year
  • BDTX N/A
  • RMM N/A
  • Revenue Next Year
  • BDTX N/A
  • RMM N/A
  • P/E Ratio
  • BDTX $28.49
  • RMM $15.55
  • Revenue Growth
  • BDTX N/A
  • RMM N/A
  • 52 Week Low
  • BDTX $1.20
  • RMM $12.32
  • 52 Week High
  • BDTX $6.75
  • RMM $16.10
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 59.61
  • RMM 54.50
  • Support Level
  • BDTX $2.43
  • RMM $13.51
  • Resistance Level
  • BDTX $2.72
  • RMM $13.58
  • Average True Range (ATR)
  • BDTX 0.17
  • RMM 0.09
  • MACD
  • BDTX -0.01
  • RMM 0.03
  • Stochastic Oscillator
  • BDTX 75.77
  • RMM 96.10

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About RMM RiverNorth Managed Duration Municipal Income Fund Inc.

RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: